Integrative Comparison of mRNA Expression Patterns in Breast Cancers from Caucasian and Asian Americans with Implications for Precision Medicine.

Asian Americans (AS) have significantly lower incidence and mortality rates of breast cancer than Caucasian Americans (CA). Although this racial disparity has been documented, the underlying pathogenetic factors explaining it are obscure. We addressed this issue by an integrative genomics approach to compare mRNA expression between AS and CA cases of breast cancer. RNA-seq data from the Cancer Genome Atlas showed that mRNA expression revealed significant differences at gene and pathway levels. Increased susceptibility and severity in CA patients were likely the result of synergistic environmental and genetic risk factors, with arachidonic acid metabolism and PPAR signaling pathways implicated in linking environmental and genetic factors. An analysis that also added eQTL data from the Genotype-Tissue Expression Project and SNP data from the 1,000 Genomes Project identified several SNPs associated with differentially expressed genes. Overall, the associations we identified may enable a more focused study of genotypic differences that may help explain the disparity in breast cancer incidence and mortality rates in CA and AS populations and inform precision medicine. Cancer Res; 77(2); 423-33. ©2016 AACR.

[1]  Weijun Luo,et al.  Pathview: an R/Bioconductor package for pathway-based data integration and visualization , 2013, Bioinform..

[2]  Jean YH Yang,et al.  Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.

[3]  F. Markowetz,et al.  The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups , 2012, Nature.

[4]  Sergio Contrino,et al.  InterMine: a flexible data warehouse system for the integration and analysis of heterogeneous biological data , 2012, Bioinform..

[5]  Ping Sun,et al.  Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States. , 2015, JAMA.

[6]  Sasha Colby,et al.  Projections of the Size and Composition of the U.S. Population: 2014 to 2060. Population Estimates and Projections. Current Population Reports. P25-1143. , 2015 .

[7]  Spencer S. Ericksen,et al.  Arachidonic and eicosapentaenoic acid metabolism by human CYP1A1: highly stereoselective formation of 17(R),18(S)-epoxyeicosatetraenoic acid. , 2004, Biochemical pharmacology.

[8]  M Ingelman-Sundberg,et al.  Cytochrome P450 pharmacogenetics and cancer , 2006, Oncogene.

[9]  M. Thun,et al.  PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3). , 2010, Carcinogenesis.

[10]  S. Koifman,et al.  Polymorphisms in cycloxygenase-2 gene and breast cancer prognosis: association between PTGS2 haplotypes and histopathological features , 2012, Breast Cancer Research and Treatment.

[11]  Kenneth J. Hillan,et al.  Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer , 2004, Nature Reviews Drug Discovery.

[12]  M. Gerstein,et al.  The Transcriptional Landscape of the Yeast Genome Defined by RNA Sequencing , 2008, Science.

[13]  J. Koo,et al.  Expression of Lipid Metabolism-Related Proteins in Metastatic Breast Cancer , 2015, PloS one.

[14]  K. Olden,et al.  Requirement of Protein Kinase Cμ Activation and Calpain-mediated Proteolysis for Arachidonic Acid-stimulated Adhesion of MDA-MB-435 Human Mammary Carcinoma Cells to Collagen Type IV* , 2004, Journal of Biological Chemistry.

[15]  J. Vadgama,et al.  Critical role of oxidative stress in estrogen-induced carcinogenesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Damian Szklarczyk,et al.  STRING v9.1: protein-protein interaction networks, with increased coverage and integration , 2012, Nucleic Acids Res..

[17]  E. Salazar,et al.  Arachidonic acid promotes FAK activation and migration in MDA-MB-231 breast cancer cells. , 2008, Experimental cell research.

[18]  M. Cleary,et al.  Minireview: Obesity and breast cancer: the estrogen connection. , 2009, Endocrinology.

[19]  M. Runge,et al.  Hypoxia Induces Cyclooxygenase-2 via the NF-κB p65 Transcription Factor in Human Vascular Endothelial Cells* , 1997, The Journal of Biological Chemistry.

[20]  Shufeng Zhou,et al.  Polymorphism of human cytochrome P450 enzymes and its clinical impact , 2009, Drug metabolism reviews.

[21]  M. Nakajima,et al.  Cytochrome P450-mediated Metabolism of Estrogens and Its Regulation in Human , 2004 .

[22]  Béatrice Desvergne,et al.  From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions. , 2006, Progress in lipid research.

[23]  Jasjeet S. Sekhon,et al.  Genetic Optimization Using Derivatives , 2011, Political Analysis.

[24]  Mark D. Robinson,et al.  Moderated statistical tests for assessing differences in tag abundance , 2007, Bioinform..

[25]  Ahmedin Jemal,et al.  Association of race/ethnicity, socioeconomic status, and breast cancer subtypes in the National Cancer Data Base (2010–2011) , 2014, Breast Cancer Research and Treatment.

[26]  E. Chang,et al.  Hidden breast cancer disparities in Asian women: disaggregating incidence rates by ethnicity and migrant status. , 2010, American journal of public health.

[27]  L. Ellis,et al.  Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  I. Ellis,et al.  Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes , 2009, Clinical Cancer Research.

[29]  Paras Gupta,et al.  The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases , 2011, Journal of advanced pharmaceutical technology & research.

[30]  A. Purohit,et al.  The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer , 2002, Breast Cancer Research.

[31]  S. Glaser,et al.  Recent trends in breast cancer incidence among 6 Asian groups in the Greater Bay Area of Northern California , 2007, International journal of cancer.

[32]  K. Mokbel,et al.  The role of cyclooxygenase-2 in breast cancer: review , 2008, Breast Cancer Research and Treatment.

[33]  Duo Li,et al.  Contribution of meat fat to dietary arachidonic acid , 1998, Lipids.

[34]  M. Stephens,et al.  RNA-seq: an assessment of technical reproducibility and comparison with gene expression arrays. , 2008, Genome research.

[35]  C. Bouchard,et al.  Severe obesity is associated with novel single nucleotide polymorphisms of the ESR1 and PPARgamma locus in Han Chinese. , 2009, The American journal of clinical nutrition.

[36]  A. Sorokin,et al.  Targeting 20-HETE producing enzymes in cancer – rationale, pharmacology, and clinical potential , 2013, OncoTargets and therapy.

[37]  Jasjeet S. Sekhon,et al.  Multivariate and Propensity Score Matching Software with Automated Balance Optimization: The Matching Package for R , 2008 .

[38]  Stampfer,et al.  PTGS 2 and IL 6 genetic variation and risk of breast and prostate cancer : results from the Breast and Prostate Cancer Cohort Consortium ( BPC 3 ) , 2010 .

[39]  Michael F. Hoffmann,et al.  Polymorphic Cytochrome P450 Enzymes (CYPs) and Their Role in Personalized Therapy , 2013, PloS one.

[40]  Jinfeng Zhang,et al.  Differentially Expressed Transcripts and Dysregulated Signaling Pathways and Networks in African American Breast Cancer , 2013, PloS one.

[41]  W. Huber,et al.  Differential expression analysis for sequence count data , 2010 .

[42]  B. Paulweber,et al.  The cyclooxygenase-2 (PTGS2) 8473T>C polymorphism is associated with breast cancer risk. , 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.

[43]  Ian O Ellis,et al.  Basal-like breast cancer: a critical review. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  Serban Nacu,et al.  Gene expression network analysis and applications to immunology , 2007, Bioinform..

[45]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumors , 2012, Nature.

[46]  Amei Amei,et al.  Cancer incidence among Asian American populations in the United States, 2009–2011 , 2016, International journal of cancer.

[47]  Y. Zhang,et al.  Critical role of arachidonic acid-activated mTOR signaling in breast carcinogenesis and angiogenesis , 2013, Oncogene.

[48]  Xuegong Zhang,et al.  DEGseq: an R package for identifying differentially expressed genes from RNA-seq data , 2010, Bioinform..

[49]  S. Ménard,et al.  Molecular portrait of breast cancer in China reveals comprehensive transcriptomic likeness to Caucasian breast cancer and low prevalence of luminal A subtype , 2015, Cancer medicine.